Critical Review: Lexaria Bioscience (OTCMKTS:LXRP) and NexMetals Mining (NASDAQ:NEXM)

Lexaria Bioscience (OTCMKTS:LXRP) and NexMetals Mining (NASDAQ:NEXM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Valuation and Earnings

This table compares Lexaria Bioscience and NexMetals Mining”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lexaria Bioscience	$380,000.00	0.00	-$4.09 million	N/A	N/A
NexMetals Mining	N/A	N/A	-$30.96 million	($1.05)	-3.60

Lexaria Bioscience has higher revenue and earnings than NexMetals Mining.

Profitability

This table compares Lexaria Bioscience and NexMetals Mining’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lexaria Bioscience	-1,046.77%	-157.62%	-148.09%
NexMetals Mining	N/A	-228.97%	-141.60%

Institutional and Insider Ownership

0.1% of Lexaria Bioscience shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations for Lexaria Bioscience and NexMetals Mining, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lexaria Bioscience	0	0	0	0	0.00
NexMetals Mining	1	1	0	0	1.50

Given Lexaria Bioscience’s higher possible upside, research analysts clearly believe Lexaria Bioscience is more favorable than NexMetals Mining.

Summary

Lexaria Bioscience beats NexMetals Mining on 5 of the 8 factors compared between the two stocks.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

About NexMetals Mining

North American Nickel Inc. operates as a mineral exploration and resource development company. The company engages in the exploration and development of mineral properties in Morocco and Canada, as well as in Botswana. Its principal asset is the Maniitsoq nickel-copper-cobalt-precious metal sulphide project covering an area of 3,048 square kilometers located in southwest Greenland. The company was formerly known as Widescope Resources Inc. and changed its name to North American Nickel Inc. in April 2010. North American Nickel Inc. was incorporated in 1983 and is headquartered in Vancouver, Canada.